119 HR 679
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Latest Action
Referred to the House Committee on Energy and Commerce.
2025-01-23
Read the Bill
Primary sources on Congress.gov:
Cosponsors (showing 10 of 18)
R · Hern, Kevin (Oklahoma)R · Bost, Mike (Illinois)R · Miller, Mary E. (Illinois)R · Weber, Randy K. Sr. (Texas)R · Babin, Brian (Texas)R · Moolenaar, John R. (Michigan)R · Webster, Daniel (Florida)R · Baird, James R. (Indiana)R · Higgins, Clay (Louisiana)R · Feenstra, Randy (Iowa)Federal Agencies on This Bill
Posts from federal agencies in the last 24 hours that match this bill's identifier or title keywords. Grouped by voice class — executive framing carries the administration's perspective; regulators speak to implementation; oversight bodies aim for neutrality. Read across, not just within, a single voice class.
Independent oversight (CBO, GAO, Federal Register, Congress.gov)
Non-partisan analysis: CBO cost scoring, GAO investigations, Federal Register rule publications, and Congress.gov legislative tracking. The closest thing to neutral framing on a bill's likely effect.
Mariner Training: Maritime Administration Should Share More Information About Financial Aid and Careers
What GAO Found Mariner students typically take training courses to begin or advance their careers, and many such courses are approved by the U.S. Coast Guard (USCG) to meet requirements for credentials to work on vessels. Institutions offering USCG-approved courses include one na
Read on gao.gov →Markets vs Bill
Cite this page
APA
Apprised.news. (n.d.). 119 HR 679: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.. Retrieved 2026-05-13, from https://apprised.news/bill/119hr679
MLA
"119 HR 679: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.." Apprised.news. Web. 2026-05-13. <https://apprised.news/bill/119hr679>.
Chicago
"119 HR 679: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.." Apprised.news. Accessed 2026-05-13. https://apprised.news/bill/119hr679.
BibTeX
@misc{apprised_119_hr_679_to_nullify_the_modifications_,
title = {119 HR 679: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.},
publisher = {Apprised.news},
url = {https://apprised.news/bill/119hr679},
note = {Accessed 2026-05-13}
}